These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 35216393)
1. A Novel Role of Arrhythmia-Related Gene Chang KT; Wu HJ; Liu CW; Li CY; Lin HY Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216393 [TBL] [Abstract][Full Text] [Related]
2. AHNAK2 Is Associated with Poor Prognosis and Cell Migration in Lung Adenocarcinoma. Zhang S; Lu Y; Qi L; Wang H; Wang Z; Cai Z Biomed Res Int; 2020; 2020():8571932. PubMed ID: 32904605 [TBL] [Abstract][Full Text] [Related]
3. Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation. Zheng Q; Wang Z; Zhang M; Yu Y; Chen R; Lu T; Liu L; Ma J; Liu T; Zheng H; Li H; Li J BMC Cancer; 2021 Nov; 21(1):1216. PubMed ID: 34774014 [TBL] [Abstract][Full Text] [Related]
4. FAM207BP, a pseudogene-derived lncRNA, facilitates proliferation, migration and invasion of lung adenocarcinoma cells and acts as an immune-related prognostic factor. Yu L; Qiao R; Xu J; Han B; Zhong R Life Sci; 2021 Mar; 268():119022. PubMed ID: 33434533 [TBL] [Abstract][Full Text] [Related]
5. Prognostic value and immune infiltration of a novel stromal/immune score-related P2RY12 in lung adenocarcinoma microenvironment. Yu L; Cao S; Li J; Han B; Zhong H; Zhong R Int Immunopharmacol; 2021 Sep; 98():107734. PubMed ID: 34175738 [TBL] [Abstract][Full Text] [Related]
6. Bioinformatics and experimental approach identify lipocalin 2 as a diagnostic and prognostic indicator for lung adenocarcinoma. Li A; Zhang K; Zhou J; Li M; Fan M; Gao H; Ma R; Gao L; Chen M Int J Biol Macromol; 2024 Jun; 272(Pt 2):132797. PubMed ID: 38848833 [TBL] [Abstract][Full Text] [Related]
7. Comprehensive analysis identifies YKT6 as a potential prognostic and diagnostic biomarker in lung adenocarcinoma. Zhang L; Wang S; Wang L BMC Cancer; 2024 Oct; 24(1):1235. PubMed ID: 39375639 [TBL] [Abstract][Full Text] [Related]
8. Overexpression of BCCIP predicts an unfavorable prognosis and promotes the proliferation and migration of lung adenocarcinoma. Shi J; Lv X; Li W; Ming Z; Zeng L; Yuan J; Chen Y; Liu B; Yang S Thorac Cancer; 2021 Sep; 12(17):2324-2338. PubMed ID: 34297484 [TBL] [Abstract][Full Text] [Related]
9. Deciphering lung adenocarcinoma prognosis and immunotherapy response through an AI-driven stemness-related gene signature. Ye B; Hongting G; Zhuang W; Chen C; Yi S; Tang X; Jiang A; Zhong Y J Cell Mol Med; 2024 Jul; 28(14):e18564. PubMed ID: 39046884 [TBL] [Abstract][Full Text] [Related]
10. Overexpression of CENPF is associated with progression and poor prognosis of lung adenocarcinoma. Li MX; Zhang MY; Dong HH; Li AJ; Teng HF; Liu AL; Xu N; Qu YQ Int J Med Sci; 2021; 18(2):494-504. PubMed ID: 33390818 [No Abstract] [Full Text] [Related]
11. P3H4 Overexpression Serves as a Prognostic Factor in Lung Adenocarcinoma. Jin X; Zhou H; Song J; Cui H; Luo Y; Jiang H Comput Math Methods Med; 2021; 2021():9971353. PubMed ID: 34257701 [TBL] [Abstract][Full Text] [Related]
12. Increased expression of TTC21A in lung adenocarcinoma infers favorable prognosis and high immune infiltrating level. Wang W; Ren S; Wang Z; Zhang C; Huang J Int Immunopharmacol; 2020 Jan; 78():106077. PubMed ID: 31812070 [TBL] [Abstract][Full Text] [Related]
13. Genome‑wide investigation of the clinical significance and prospective molecular mechanisms of kinesin family member genes in patients with lung adenocarcinoma. Zhang L; Zhu G; Wang X; Liao X; Huang R; Huang C; Huang P; Zhang J; Wang P Oncol Rep; 2019 Sep; 42(3):1017-1034. PubMed ID: 31322267 [TBL] [Abstract][Full Text] [Related]
14. The low expression of NUP62CL indicates good prognosis and high level of immune infiltration in lung adenocarcinoma. Ren S; Wang W; Zhang C; Sun Y; Sun M; Wang Y; Zhang X; Lu B; Yao L Cancer Med; 2021 May; 10(10):3403-3412. PubMed ID: 33934535 [TBL] [Abstract][Full Text] [Related]
15. Prognostic value and molecular mechanisms of OAS1 in lung adenocarcinoma. Wang L; Gao L; Ding F; Gao K; Liu Q; Yin X BMC Pulm Med; 2024 Sep; 24(1):473. PubMed ID: 39334033 [TBL] [Abstract][Full Text] [Related]
16. Construction of the optimization prognostic model based on differentially expressed immune genes of lung adenocarcinoma. Zhai Y; Zhao B; Wang Y; Li L; Li J; Li X; Chang L; Chen Q; Liao Z BMC Cancer; 2021 Mar; 21(1):213. PubMed ID: 33648465 [TBL] [Abstract][Full Text] [Related]
17. A Seven-Gene Signature with Close Immune Correlation Was Identified for Survival Prediction of Lung Adenocarcinoma. Zou X; Hu Z; Huang C; Chang J Med Sci Monit; 2020 Jul; 26():e924269. PubMed ID: 32613949 [TBL] [Abstract][Full Text] [Related]
18. A two-circular RNA signature as a noninvasive diagnostic biomarker for lung adenocarcinoma. Liu XX; Yang YE; Liu X; Zhang MY; Li R; Yin YH; Qu YQ J Transl Med; 2019 Feb; 17(1):50. PubMed ID: 30777071 [TBL] [Abstract][Full Text] [Related]
19. Identification of theranostic factors for patients developing metastasis after surgery for early-stage lung adenocarcinoma. Cheng WC; Chang CY; Lo CC; Hsieh CY; Kuo TT; Tseng GC; Wong SC; Chiang SF; Huang KC; Lai LC; Lu TP; Chao KSC; Sher YP Theranostics; 2021; 11(8):3661-3675. PubMed ID: 33664854 [No Abstract] [Full Text] [Related]
20. Oncogenic role of abnormal spindle‑like microcephaly‑associated protein in lung adenocarcinoma. Wang J; Liang J; Li H; Han J; Jiang J; Li Y; Feng Z; Zhao R; Tian H Int J Oncol; 2021 May; 58(5):. PubMed ID: 33786609 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]